(Q34203281)

English

In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Candida glabrata

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael G. Rinaldi

5

object named as

Michael G Rinaldi

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Deanna A. Sutton

4

object named as

Deanna A Sutton

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annette W. Fothergill

3

object named as

Annette W Fothergill

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Sofia Perea

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Gloria Gonzalez

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1831-1833

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

An evaluation of the in vitro activity of terbinafine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

Current and emerging azole antifungal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

5 July 2018

The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130943

28 October 2018

[Epidemiology of yeast colonization and oropharyngeal infection other than Candida albicans in patients with HIV infection]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11980970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans

1 reference

https://pubmed.ncbi.nlm.nih.gov/11980970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11980970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.40.5.1831-1833.2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34203281&oldid=1982172928"